questionText: To ask the Secretary of State for Health and Social Care, whether he plans to make difluoromethylornithine available on the NHS for children with high-risk neuroblastoma.
answerText: We understand how important it is that cancer patients are able to benefit from rapid access to effective new treatments. We are aware that the manufacturer difluoromethylornithine (DFMO) has applied for a United Kingdom marketing authorisation through Pr...
heading: Neuroblastoma: Drugs